首页> 外国专利> PHARMACEUTICAL COMPOSITION CONTAINING SOX-Trio GENE-INDUCED STEM CELLS AND FIBRIN GEL FOR PROMOTING CHONDROGENESIS

PHARMACEUTICAL COMPOSITION CONTAINING SOX-Trio GENE-INDUCED STEM CELLS AND FIBRIN GEL FOR PROMOTING CHONDROGENESIS

机译:包含SOX-三聚体基因诱导的干细胞和纤维蛋白凝胶的药物组合物,可促进软骨形成

摘要

PURPOSE: A pharmaceutical composition containing SOX-Trio gene-induced stem cells and fibrin gel for promoting chondrogenesis is provided to promote differentiation of chondrocytes without cytotoxicity and to suppress chondrocyte pachynesis.;CONSTITUTION: A pharmaceutical composition for promoting chondrogenesis contains fibrin gel and stem cells in which SOX-5, SOX-6, and SOX-9 genes are introduced by a retrovirus vector. The stem cells are embryonic stem cells or adult stem cells. The adult stem cells are selected among stem cells derived from bone marrow, fat, umbilical cord blood, and umbilical cord.;COPYRIGHT KIPO 2013
机译:目的:提供一种药物组合物,其包含SOX-Trio基因诱导的干细胞和纤维蛋白凝胶,以促进软骨形成,以促进软骨细胞的分化而无细胞毒性并抑制软骨细胞的粉刺。其中逆转录病毒载体导入了SOX-5,SOX-6和SOX-9基因。干细胞是胚胎干细胞或成年干细胞。成年干细胞选自骨髓,脂肪,脐带血和脐带血的干细胞。; COPYRIGHT KIPO 2013

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号